Surgery – Diagnostic testing – Liquid collection
Reexamination Certificate
2005-01-11
2005-01-11
Hindenburg, Max F. (Department: 3736)
Surgery
Diagnostic testing
Liquid collection
C600S306000, C604S290000
Reexamination Certificate
active
06840910
ABSTRACT:
The present invention relates to a method of distributing a skin care product to a subject, the method including the steps of: (a) obtaining a sample of interstitial fluid from the skin of the subject; (b) measuring the amount of a skin analyte in the sample; and (c) distributing a skin care product to the subject to alter the amount of the skin analyte in the skin of the subject.
REFERENCES:
patent: 4775361 (1988-10-01), Jacques et al.
patent: 4863970 (1989-09-01), Patel et al.
patent: 5155992 (1992-10-01), Follensbee et al.
patent: 5250023 (1993-10-01), Lee et al.
patent: 5445611 (1995-08-01), Eppstein et al.
patent: 5843114 (1998-12-01), Jang
patent: 5885211 (1999-03-01), Eppstein et al.
patent: 6022316 (2000-02-01), Eppstein et al.
patent: 6027496 (2000-02-01), Loomis et al.
patent: 6056738 (2000-05-01), Marchitto et al.
patent: 6155992 (2000-12-01), Henning et al.
patent: 6173202 (2001-01-01), Eppstein
patent: 20030078518 (2003-04-01), Skover
patent: 20030083558 (2003-05-01), Skover
patent: 43 13 258 (1994-10-01), None
patent: 101 00 127 (2002-10-01), None
patent: 1 098 589 (2001-05-01), None
patent: 2 358 706 (2001-08-01), None
patent: 2001187205 (2001-07-01), None
patent: WO 9704832 (1997-02-01), None
patent: WO 9707734 (1997-03-01), None
patent: WO 9708987 (1997-03-01), None
patent: WO 9710745 (1997-03-01), None
patent: WO 9742882 (1997-11-01), None
patent: WO 9742888 (1997-11-01), None
patent: WO 9748440 (1997-12-01), None
patent: WO 9800193 (1998-01-01), None
patent: WO 9811937 (1998-03-01), None
patent: WO 9907277 (1999-02-01), None
patent: WO 9920181 (1999-04-01), None
patent: WO 9927852 (1999-06-01), None
patent: WO 9940848 (1999-08-01), None
patent: WO 9944507 (1999-09-01), None
patent: WO 9944637 (1999-09-01), None
patent: WO 9944638 (1999-09-01), None
patent: WO 9944678 (1999-09-01), None
patent: WO 0003758 (2000-01-01), None
patent: WO 0004821 (2000-02-01), None
patent: WO 0010579 (2000-03-01), None
patent: WO 0015102 (2000-03-01), None
patent: WO 0015188 (2000-03-01), None
patent: WO 0035530 (2000-06-01), None
patent: WO 0054920 (2000-09-01), None
patent: WO 0059373 (2000-10-01), None
patent: WO 0074763 (2000-12-01), None
patent: WO 0074764 (2000-12-01), None
patent: WO 0074766 (2000-12-01), None
patent: 2000352566 (2000-12-01), None
patent: WO 0113989 (2001-03-01), None
patent: WO 0128423 (2001-04-01), None
patent: WO 02082093 (2002-10-01), None
patent: WO 02095358 (2002-11-01), None
Rajadhyaksha et al, Oxazolidinones: Optimizing Delivery of Active Ingredients in Skin Care Products, Mar. 1996, Drug & Cosmetic Industry, vol. 158, No. 3, p. 36.*
Wilson, R., Antioxidants to Augment the Efficacy of Sunscreens, Aug. 1992, Drug & Cosmetic Industry, vol. 151, No. 2, p. 32.*
Badcock, N.R. et al., “The Pharmacokinetics of Ketoconazole after Chronic Administration in Adults”,Eur J. Clin Pharmacol, 1987, 33, 531-534.
Bork, K. et al., “Histamine Levels in Interstitial Fluid of Lesional and Perilesional Skin in Patients with Chronic Idiopathic Urticaria”,Arch Dermatol Res., 1979, 266, 269-276.
Svedman,Pharm. Res., 1988, 15(6), 883-888.
Henry, et al., “Microfabricated Microneedles: A Novel Approach to Transdermal Drug Delivery”,Journal of Pharmaceutical Sciences, 1988, 87(8), 922-925.
Krogstad, A.L. et al., “Microdialysis methodology for the measurement of dermal interstitial fluid in humans”British Journal of Dermatology, 1996, 134(6), 1005-1012.
“Laboratory Procedures Used by the Clinical Chemistry Division, Centers for Disease Control, for the Second Health and Nutrition Examination Survey” (Hanes II)1976-1980, USDHS, Public Health Services, IV., Analytical Methods, Vitamin C, Atlanta, Ga.
Maile, L.A. et al., “Active and Inhibitory Components of the Insulin-Like Growth Factor Binding Protein-3 Protease System in Adult Serum, Interstital, and Synovial Fluid”,Endrocrinology, 1998, 139(12), 4772-4781, XP-002230077.
Service, F.J. et al., “Dermal Interstitial Glucose as an Indicator of Ambient Glycemia”,Diabetes Care, 1997, 20(9), 1426-1429.
Svedman, P. et al., “Skin Mini-Erosion Sampling Technique: Feasibility Study with Regard to Serial Glucose Measurement”,Pharmaceutical Research, 1998, 15(6), 883-888.
Tope, W.D., “Multi-Electrode Radio Frequency Resurfacing of Ex Vivo Human Skin”,Dermatol Surg, 1999, 25, 348-352.
Vaillant, et al.,Eur. J. Clin. Pharmacol, 1987, 33(5), 529-530.
Zimmerli, W. et al., “Pharmacokinetics of Cefetamet in Plasma and Skin Blister Fluid”,Antimicrobial Agents and Chemotheraphy, 1996, 40(1), 102-104.
Gabor, “Sensors in Biomedical Applications”,Technomic Pub Co., 2000, 223-306.
International Cosmetic Ingredient Dictionary and Handbook, 1997, 7thEdition(2), 1650-1667, 1626.
Liron, et al., “Novel Approaches in Biosensors and Rapid Diagnostic Assays”,Plenum Pub Corp., 2000.
Laboratory Procedures used by the Clinical Chemistry Division, Centers for Disease Control, for the Second health and Nutrition Examination Survey (HANESII),U.S. Dept of Health and Human Services, Public Health Services, Atlanta. Georgia, 1979, 17-19, 69.
U.S. Appl. No. 09/920,136, Skover.
U.S. Appl. No. 09/920,266, Skover.
Hindenburg Max F.
Johnson & Johnson Consumer Companies Inc.
McCrosky David J.
LandOfFree
Method of distributing skin care products does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of distributing skin care products, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of distributing skin care products will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3378165